AdaptHealth Stock Price, News & Analysis (NASDAQ:AHCO) $8.56 -0.64 (-6.96%) (As of 04:00 PM ET) Add Compare Share Share Today's Range$8.28▼$9.2350-Day Range$6.50▼$9.2052-Week Range$6.37▼$23.00Volume725,427 shsAverage Volume1.27 million shsMarket Capitalization$1.17 billionP/E RatioN/ADividend YieldN/APrice Target$13.83 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media AdaptHealth MarketRank™ Stock AnalysisAnalyst RatingHold2.33 Rating ScoreUpside/Downside64.6% Upside$13.83 Price TargetShort InterestBearish11.51% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.00Based on 2 Articles This WeekInsider TradingN/AProj. Earnings Growth24.19%From $0.62 to $0.77 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.28 out of 5 starsMedical Sector303rd out of 949 stocksHome Health Care Services Industry4th out of 6 stocks 3.2 Analyst's Opinion Consensus RatingAdaptHealth has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 3 buy ratings, 2 hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $13.83, AdaptHealth has a forecasted upside of 64.6% from its current price of $8.40.Amount of Analyst CoverageAdaptHealth has only been the subject of 3 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted11.51% of the float of AdaptHealth has been sold short.Short Interest Ratio / Days to CoverAdaptHealth has a short interest ratio ("days to cover") of 6.2.Change versus previous monthShort interest in AdaptHealth has recently increased by 1.35%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldAdaptHealth does not currently pay a dividend.Dividend GrowthAdaptHealth does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AHCO. Previous Next 0.0 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 2 news articles for AdaptHealth this week, compared to 3 articles on an average week.Search InterestOnly 2 people have searched for AHCO on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added AdaptHealth to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, AdaptHealth insiders have not sold or bought any company stock.Percentage Held by Insiders13.60% of the stock of AdaptHealth is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions82.67% of the stock of AdaptHealth is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.8 Earnings and Valuation Earnings GrowthEarnings for AdaptHealth are expected to grow by 24.19% in the coming year, from $0.62 to $0.77 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of AdaptHealth is -2.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of AdaptHealth is -2.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioAdaptHealth has a PEG Ratio of 0.87. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioAdaptHealth has a P/B Ratio of 0.52. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About AdaptHealth Stock (NASDAQ:AHCO)AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, including CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.Read More AHCO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AHCO Stock News HeadlinesDecember 5, 2023 | stockhouse.comINVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in AdaptHealth Corp. with Losses of $100,000 to Contact the FirmDecember 4, 2023 | benzinga.comRobbins LLP Reminds Investors of Pending Lead Plaintiff Deadline in AdaptHealth Corp. (AHCO) Class ActionDecember 5, 2023 | Edge On The Street (Ad)The Battery Metal Nobody Told You AboutAccording to McKinsey and Company, the battery storage market is growing rapidly, especially with the transition to clean, renewable energy. Lithium-ion batteries still grab most of the headlines. But analysts now call safe and long-lasting batteries made with vanadium "the future of battery tech." December 1, 2023 | americanbankingnews.comAdaptHealth Corp. (NASDAQ:AHCO) Given Consensus Recommendation of "Hold" by BrokeragesNovember 26, 2023 | benzinga.comTOP RANKED ROSEN LAW FIRM Encourages AdaptHealth Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AHCONovember 25, 2023 | benzinga.comAHCO NOTICE: ROSEN, TOP RANKED GLOBAL COUNSEL,...November 24, 2023 | markets.businessinsider.comROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages AdaptHealth Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AHCONovember 22, 2023 | barrons.comDEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in AdaptHealth Corp. with Losses of $100,000 to Contact the FirmDecember 5, 2023 | Edge On The Street (Ad)The Battery Metal Nobody Told You AboutAccording to McKinsey and Company, the battery storage market is growing rapidly, especially with the transition to clean, renewable energy. Lithium-ion batteries still grab most of the headlines. But analysts now call safe and long-lasting batteries made with vanadium "the future of battery tech." November 20, 2023 | benzinga.comAHCO Investors Have Opportunity to Lead AdaptHealth Corp. Securities Fraud LawsuitNovember 19, 2023 | barrons.comAHCO Class Action Alert: Bronstein, Gewirtz & Grossman LLC Reminds AdaptHealth Corp. Investors with Substantial Losses to Contact the Firm!November 10, 2023 | finance.yahoo.comAdaptHealth Corp. to Participate in Upcoming Investor ConferencesNovember 10, 2023 | benzinga.comAHCO INVESTOR ALERT: Contact Robbins LLP for Information about Your Rights Against AdaptHealth Corp.November 9, 2023 | benzinga.comDEADLINE ALERT for SPWR, AHCO, and DCGO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of ShareholdersNovember 9, 2023 | benzinga.comFILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of AdaptHealth Corp. - AHCONovember 8, 2023 | finance.yahoo.comAdaptHealth Corp. (NASDAQ:AHCO) Q3 2023 Earnings Call TranscriptNovember 8, 2023 | markets.businessinsider.comAnalyst Expectations for AdaptHealth's FutureNovember 7, 2023 | markets.businessinsider.comWhy AdaptHealth Stock Trading Is Lower TodayNovember 7, 2023 | markets.businessinsider.comAdaptHealth Turns To Q3 Loss, But Revenue IncreasesNovember 7, 2023 | finance.yahoo.comAdaptHealth Corp (AHCO) Reports 6.3% Increase in Q3 Net Revenue Despite Net LossNovember 7, 2023 | finance.yahoo.comAdaptHealth Corp. Announces Third Quarter 2023 ResultsNovember 6, 2023 | msn.comAdaptHealth Q3 2023 Earnings PreviewNovember 6, 2023 | barrons.comAdaptHealth Corp. (AHCO) Shareholders with Significant Losses Should Contact Robbins LLP for Information about the AdaptHealth Corp. Class ActionNovember 3, 2023 | benzinga.comAdaptHealth Corp. (AHCO) Class Action: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Case Against AdaptHealth Corp.November 2, 2023 | businesswire.comEQUITY ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages AdaptHealth Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AHCONovember 1, 2023 | markets.businessinsider.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AdaptHealth Corp. - AHCOOctober 31, 2023 | benzinga.comAdaptHealth Corp. (AHCO) Shareholder Notice: Robbins LLP Reminds Investors of Class Action Against AdaptHealth Corp.See More Headlines Receive AHCO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AdaptHealth and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/07/2023Today12/05/2023Fiscal Year End12/31/2023Next Earnings (Estimated)2/26/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:AHCO CUSIPN/A CIK1725255 Webwww.adapthealth.com Phone(610) 424-4515FaxN/AEmployees10,900Year FoundedN/APrice Target and Rating Average Stock Price Target$13.83 High Stock Price Target$23.00 Low Stock Price Target$6.50 Potential Upside/Downside+61.5%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)($3.42) Trailing P/E RatioN/A Forward P/E Ratio13.81 P/E Growth0.87Net Income$69.32 million Net Margins-13.68% Pretax Margin-14.38% Return on Equity4.09% Return on Assets1.65% Debt Debt-to-Equity Ratio1.23 Current Ratio1.31 Quick Ratio1.05 Sales & Book Value Annual Sales$2.97 billion Price / Sales0.39 Cash Flow$3.01 per share Price / Cash Flow2.84 Book Value$16.01 per share Price / Book0.53Miscellaneous Outstanding Shares136,390,000Free Float117,841,000Market Cap$1.17 billion OptionableNot Optionable Beta0.87 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Richard Alan Barasch (Age 69)Chairman of the Board & Interim CEO Comp: $102.5kMr. Joshua Parnes (Age 44)President & Director Comp: $1.04MMr. Jason A. Clemens C.F.A. (Age 44)Chief Financial Officer Comp: $870.2kMr. Albert A. Prast (Age 63)Chief Technology Officer Comp: $738.03kMr. Christopher J. Joyce (Age 59)Secretary Comp: $790.71kMr. Shaw A. Rietkerk (Age 48)Chief Operating Officer Comp: $488.56kMs. Christine Archbold (Age 48)Chief Accounting Officer Anton HieVice President of Investor RelationsMs. Wendy RussalesiChief Compliance OfficerMs. Leila VargasExecutive Vice President of Sales & MarketingMore ExecutivesKey CompetitorsAddus HomeCareNASDAQ:ADUSAveanna HealthcareNASDAQ:AVAHAmedisysNASDAQ:AMEDOPKO HealthNASDAQ:OPKViking TherapeuticsNASDAQ:VKTXView All CompetitorsInsiders & InstitutionsDimension Capital Management LLCSold 5,833 shares on 12/1/2023Ownership: 0.134%American Century Companies Inc.Bought 8,795 shares on 11/30/2023Ownership: 0.019%Deutsche Bank AGBought 13,774 shares on 11/24/2023Ownership: 0.036%Public Sector Pension Investment BoardSold 34,815 shares on 11/22/2023Ownership: 0.074%Graham Capital Management L.P.Bought 29,142 shares on 11/22/2023Ownership: 0.021%View All Insider TransactionsView All Institutional Transactions AHCO Stock Analysis - Frequently Asked Questions Should I buy or sell AdaptHealth stock right now? 6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for AdaptHealth in the last year. There are currently 1 sell rating, 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" AHCO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AHCO, but not buy additional shares or sell existing shares. View AHCO analyst ratings or view top-rated stocks. What is AdaptHealth's stock price target for 2024? 6 brokers have issued 12 month price targets for AdaptHealth's stock. Their AHCO share price targets range from $6.50 to $23.00. On average, they predict the company's stock price to reach $13.83 in the next year. This suggests a possible upside of 64.6% from the stock's current price. View analysts price targets for AHCO or view top-rated stocks among Wall Street analysts. How have AHCO shares performed in 2023? AdaptHealth's stock was trading at $19.22 at the beginning of the year. Since then, AHCO shares have decreased by 56.3% and is now trading at $8.40. View the best growth stocks for 2023 here. When is AdaptHealth's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, February 26th 2024. View our AHCO earnings forecast. How were AdaptHealth's earnings last quarter? AdaptHealth Corp. (NASDAQ:AHCO) issued its quarterly earnings data on Tuesday, November, 7th. The company reported $0.19 EPS for the quarter, meeting analysts' consensus estimates of $0.19. The business earned $804.03 million during the quarter, compared to analysts' expectations of $796.60 million. AdaptHealth had a positive trailing twelve-month return on equity of 4.09% and a negative net margin of 13.68%. The business's revenue for the quarter was up 6.3% on a year-over-year basis. During the same quarter last year, the firm earned $0.11 earnings per share. What ETFs hold AdaptHealth's stock? ETFs with the largest weight of AdaptHealth (NASDAQ:AHCO) stock in their portfolio include SPDR S&P Health Care Services ETF (XHS), Janus Henderson Small Cap Growth Alpha ETF (JSML), Invesco S&P SmallCap Value with Momentum ETF (XSVM), Invesco S&P SmallCap Health Care ETF (PSCH), Harbor Small Cap Explorer ETF (QWST), Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD) and EA Bridgeway Omni Small-Cap Value ETF (BSVO).Syntax Stratified SmallCap ETF (SSLY). What other stocks do shareholders of AdaptHealth own? Based on aggregate information from My MarketBeat watchlists, some companies that other AdaptHealth investors own include Advanced Micro Devices (AMD), Johnson & Johnson (JNJ), Advance Auto Parts (AAP), American International Group (AIG), Biogen (BIIB), BioMarin Pharmaceutical (BMRN), Bristol-Myers Squibb (BMY), Caterpillar (CAT), Cisco Systems (CSCO) and CVS Health (CVS). Who are AdaptHealth's major shareholders? AdaptHealth's stock is owned by a number of institutional and retail investors. Top institutional investors include Deerfield Management Company L.P. Series C (10.00%), FMR LLC (6.49%), SkyKnight Capital L.P. (6.30%), Reinhart Partners LLC. (2.66%), Rubric Capital Management LP (1.44%) and Rubric Capital Management LP (1.44%). Insiders that own company stock include Aero Holdings Ii Ll Skyknight, Alan G Quasha, Albert A Prast, Assured Investment Management, Christopher J Joyce, Dale B Wolf, Daniel Bunting, Everest Hill Group Inc, Frank Mullen, Jason A Clemens, Ronald T Mcdaniel, Shaw Rietkerk, Skyknight Aero Holdings, Llc, Skyknight Capital Fund Ii, LP and Stephen P Griggs. View institutional ownership trends. How do I buy shares of AdaptHealth? Shares of AHCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NASDAQ:AHCO) was last updated on 12/5/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AdaptHealth Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.